You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Details for New Drug Application (NDA): 219444

✉ Email this page to a colleague

« Back to Dashboard

NDA 219444 describes DEHYDRATED ALCOHOL, which is a drug marketed by Accord Hlthcare, Breckenridge, Ingenus Pharms Llc, Xgen Pharms, and Royal Pharms, and is included in five NDAs. It is available from seven suppliers. Additional details are available on the DEHYDRATED ALCOHOL profile page.

The generic ingredient in DEHYDRATED ALCOHOL is dehydrated alcohol. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the dehydrated alcohol profile page.

Summary for 219444

Tradename:	DEHYDRATED ALCOHOL
Applicant:	Breckenridge
Ingredient:	dehydrated alcohol
Patents:	0

Suppliers and Packaging for NDA: 219444

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
DEHYDRATED ALCOHOL	dehydrated alcohol	SOLUTION;INTRA-ARTERIAL	219444	ANDA	Breckenridge Pharmaceutical Inc	51991-999	51991-999-17	10 VIAL, GLASS in 1 CARTON (51991-999-17) / 5 mL in 1 VIAL, GLASS (51991-999-75)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION;INTRA-ARTERIAL			Strength	99% (5ML)
Approval Date:	Jun 23, 2025	TE:	AP	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.